These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9547461)

  • 1. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease.
    MacQueen GM; Rosebush PI; Mazurek MF
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):10-9. PubMed ID: 9547461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system.
    Miklyaeva EI; Dong W; Bureau A; Fattahie R; Xu Y; Su M; Fick GH; Huang JQ; Igdoura S; Hanai N; Gravel RA
    Brain Res; 2004 Mar; 1001(1-2):37-50. PubMed ID: 14972652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric aspects of adult-onset Tay-Sachs disease: two case reports with several new findings.
    Hurowitz GI; Silver JM; Brin MF; Williams DT; Johnson WG
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):30-6. PubMed ID: 8428133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.
    Rosebush PI; MacQueen GM; Clarke JT; Callahan JW; Strasberg PM; Mazurek MF
    J Clin Psychiatry; 1995 Aug; 56(8):347-53. PubMed ID: 7635850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tay-Sachs disease].
    Tanaka A
    Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.
    Neudorfer O; Pastores GM; Zeng BJ; Gianutsos J; Zaroff CM; Kolodny EH
    Genet Med; 2005 Feb; 7(2):119-23. PubMed ID: 15714079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a patient affected by "Juvenile-chronic" Tay Sachs disease in South Italy.
    Liguori M; Tagarelli G; Romeo N; Bagalà A; Spadafora P
    Neurol Sci; 2016 Nov; 37(11):1883-1885. PubMed ID: 27351546
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.
    Fullam S; Togher Z; Power A; Kennelly L; McHugh JC; O'Dowd S; Tubridy N; Hardiman O; Costigan D; Ryan A; Lefter S; Connolly S; Murphy SM
    Eur J Neurol; 2024 Jan; 31(1):e16069. PubMed ID: 37754769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History of Adult Patients with GM2 Gangliosidosis.
    Masingue M; Dufour L; Lenglet T; Saleille L; Goizet C; Ayrignac X; Ory-Magne F; Barth M; Lamari F; Mandia D; Caillaud C; Nadjar Y
    Ann Neurol; 2020 Apr; 87(4):609-617. PubMed ID: 31995250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tay-Sachs disease in non-Jewish infant in Israel].
    Nadim N
    Harefuah; 2012 Jan; 151(1):16-7, 63. PubMed ID: 22670494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric features of adult GM2 gangliosidosis.
    Streifler J; Golomb M; Gadoth N
    Br J Psychiatry; 1989 Sep; 155():410-3. PubMed ID: 2611559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nursing challenge: adult-onset Tay-Sachs disease.
    Hamilton D
    Arch Psychiatr Nurs; 1991 Dec; 5(6):382-5. PubMed ID: 1759864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
    Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
    Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic deficiencies of beta-N-acetylhexosaminidase A and B: Tay-Sachs and Sandhoff diseases (GM2-gangliosidosis)].
    Suzuki K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):721-7. PubMed ID: 2978703
    [No Abstract]   [Full Text] [Related]  

  • 18. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
    Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
    Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives for Tay-Sachs disease.
    Desnick RJ; Kaback MM
    Adv Genet; 2001; 44():349-56. PubMed ID: 11596996
    [No Abstract]   [Full Text] [Related]  

  • 20. Paranoid delusion as lead symptom in two siblings with late-onset Tay-Sachs disease and a novel mutation in the HEXA gene.
    Stendel C; Gallenmüller C; Peters K; Bürger F; Gramer G; Biskup S; Klopstock T
    J Neurol; 2015; 262(4):1072-3. PubMed ID: 25860343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.